PA
FOLD

Para Advisors’s Amicus Therapeutics FOLD Stock Holding History

Para Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$74K Buy
+10,000
New +$67.5K 0.42% 10

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Para Advisors's FOLD Position: Q3 2016 in Review

Para Advisors opened a new position in Amicus Therapeutics (FOLD) in Q3 2016: 10,000 shares worth $74K. The stake represents 0.42% of the portfolio and ranks #10 among its holdings.

136 funds tracked by Wall St. Rank hold FOLD as of Q3 2016.

  • Para Advisors held 10,000 shares of Amicus Therapeutics worth $74K as of Q3 2016.
  • Amicus Therapeutics was a new Para Advisors position in Q3 2016.
  • Amicus Therapeutics made up 0.42% of Para Advisors's portfolio in Q3 2016, its #10 holding.
  • 136 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2016.

Based on Para Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.